1 Immunoprecise Antibodies Ltd Receivables Turnover Ratio (IPA), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

At a Glance

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Immunoprecise Antibodies Ltd (NASDAQ: IPA)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Immunoprecise Antibodies Ltd Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics

According to Immunoprecise Antibodies Ltd Balance Sheet, in the third quarter 2026, company has not reported any Accounts receivable.
See Immunoprecise Antibodies Ltd Balance Sheet

If we take a look into Healthcare sector Immunoprecise Antibodies Ltd achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Immunoprecise Antibodies Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IPA Receivables Turnover Ratio	(Jan 31 2026) III. Quarter	(Oct 31 2025) II. Quarter	(Jul 31 2025) I. Quarter	(Apr 30 2025) IV. Quarter	(Jan 31 2025) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	56.2 %	51.5 %	27.38 %	-36.56 %	-58.3 %
Receivable Turnover Ratio (TTM)	-	-	-	-	-
IPA's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	0.9 %	29.22 %	-80.69 %	520.49 %	-2.14 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

IPA Company Profile • Back to IPA Efficiency Comparisons • Compare IPA Receivables Turnover Ratio to its Competitors

Financial Statements
Immunoprecise Antibodies Ltd 's Accounts Receivable	$ 0 Millions	Visit IPA's Balance sheet
Immunoprecise Antibodies Ltd 's Sales TTM	$ 20 Millions	Visit IPA's Income Statement
Sources of IPA's Revenues		Visit IPA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IPA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IPA's Growth Rates	IPA's Roa	IPA's Inventory Turnover Ratio	IPA's Dividend Comparisons
IPA's Profitability Ratios	IPA's Roi	IPA's Asset Turnover Ratio	IPA's Dividend Growth
IPA's Valuation Ratios	IPA's Roe	IPA's Financial Strength Ratios	IPA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jan 31 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jan 31 2026

Receivable at quarter ending Jan 31 2026

Date modified: 2026-10-15T05:23:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.